SOLICITATION NOTICE
B -- Study
- Notice Date
- 1/23/2006
- Notice Type
- Solicitation Notice
- NAICS
- 541720
— Research and Development in the Social Sciences and Humanities
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, Office of Administration, 6011 Executive Blvd, Rm 538, Rockville, MD, 20892-7663
- ZIP Code
- 20892-7663
- Solicitation Number
- 263-2006-p-(DQ)-0030
- Response Due
- 2/7/2006
- Description
- The National Institutes of Health (NIH) intends to negotiate and award a sole source purchase order utilizing simplified acquisition procedures (FAR part 13) to Emory University to develop genetic tests for rare diseases in newborns such as inborn errors of metabolism and can provide biochemical genetic analysis when genetic mutation analysis alone is not sufficient or appropriate. The purpose of this announcement is for information purposes alone and is not an invitation to submit competitive quotations 1. The period of performance shall be one year from the date of award. 2. The Contractor shall develop four to six genetic tests for rare diseases in newborns within a year after award and make them available to the public for at least five years. 3. The Contractor?s laboratory shall provide high quality, state-of-the-art, molecular genetic testing services for many rare genetic disorders. 4. The Contractor?s laboratory shall be equipped with QuiagenEZ and M48 Biorobots, ABI Sequencers, a Luminex bead array reader and a Storm imaging system. 5. The Contractor?s laboratory shall offer testing for over fifty different disorders that include cystic fibrosis, hemochromatosis, fragile-x syndrome, and galactosemia. 6. The Contractor?s laboratory shall be Clinical Laboratory Improvement Amendments (CLIA) certified. 7. The Contractor shall participate in College of American Pathologists (CAP) proficiency testing. 8. The Contractor?s Director shall be certified by the American Board of Medical Genetics. 9. The Contractor?s staff shall be National Credentialing Agency for Laboratory Personnel (NCA) certified technicians with extensive experience. 10. The Contractor?s staff shall have Ph. D.?s in the field of medical/human genetics. 11. The Contractor shall outline procedures to develop the test and educational materials for the clinical domain. 12. The Contractor shall outline quality control procedures including eradication of false positives and false negatives. 13. The Contractor shall develop the test for clinical application and associated educational materials. 14. The Contractor shall develop a report mechanism and report for five years to the Office of Rare Diseases: the number of tests undertaken for each rare genetic rare condition. who requested the test. what queries the laboratory received on the understandability of the test. who had questions about the test and/or test results (e.g. healthcare provider or patient/family). what kind of questions were asked. any other information that would be helpful to know for ORD to improve the future process of developing tests for rare genetic diseases. 15. The Contractor shall identify the need and content for additional or different educational materials. It is the Government?s belief that these requirements may only be met by Emory University. This is not a formal solicitation, however, concerns that respond to this notice must furnish concise responses directed specifically to the requirements mentioned above. Sources demonstrating the capability to accomplish the above shall supply pertinent information in sufficient detail to demonstrate their ability to perform. Information furnished shall include enough material to perform a proper evaluation. Respondents will not be notified of the evaluation results.
- Record
- SN00971245-W 20060125/060123212515 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |